These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28948854)

  • 21. Archaeosomes and Gas Vesicles as Tools for Vaccine Development.
    Adamiak N; Krawczyk KT; Locht C; Kowalewicz-Kulbat M
    Front Immunol; 2021; 12():746235. PubMed ID: 34567012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.
    Stark FC; Agbayani G; Sandhu JK; Akache B; McPherson C; Deschatelets L; Dudani R; Hewitt M; Jia Y; Krishnan L; McCluskie MJ
    Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31771150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.
    Renner TM; Akache B; Stuible M; Rohani N; Cepero-Donates Y; Deschatelets L; Dudani R; Harrison BA; Baardsnes J; Koyuturk I; Hill JJ; Hemraz UD; Régnier S; Lenferink AEG; Durocher Y; McCluskie MJ
    Front Immunol; 2023; 14():1182556. PubMed ID: 37122746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Archaeal lipid vaccine adjuvants for induction of cell-mediated immunity.
    Haq K; Jia Y; Krishnan L
    Expert Rev Vaccines; 2016 Dec; 15(12):1557-1566. PubMed ID: 27276183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Archaeosomes as novel antigen delivery systems.
    Sprott GD; Tolson DL; Patel GB
    FEMS Microbiol Lett; 1997 Sep; 154(1):17-22. PubMed ID: 9297816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
    Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
    J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.
    Krishnan L; Sprott GD
    Vaccine; 2008 Apr; 26(17):2043-55. PubMed ID: 18343538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses.
    Sprott GD; Dicaire CJ; Gurnani K; Deschatelets LA; Krishnan L
    Vaccine; 2004 Jun; 22(17-18):2154-62. PubMed ID: 15149772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology.
    Jia Y; Agbayani G; Chandan V; Iqbal U; Dudani R; Qian H; Jakubek Z; Chan K; Harrison B; Deschatelets L; Akache B; McCluskie MJ
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes.
    Omri A; Agnew BJ; Patel GB
    Int J Toxicol; 2003; 22(1):9-23. PubMed ID: 12573945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.
    Gonzalez RO; Higa LH; Cutrullis RA; Bilen M; Morelli I; Roncaglia DI; Corral RS; Morilla MJ; Petray PB; Romero EL
    BMC Biotechnol; 2009 Aug; 9():71. PubMed ID: 19678953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
    Krishnan L; Sad S; Patel GB; Sprott GD
    Cancer Res; 2003 May; 63(10):2526-34. PubMed ID: 12750276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice.
    Patel GB; Ponce A; Zhou H; Chen W
    J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polar Lipid Fraction E from
    Ayesa U; Chong PL
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes.
    Omri A; Makabi-Panzu B; Agnew BJ; Sprott GD; Patel GB
    J Drug Target; 2000; 7(5):383-92. PubMed ID: 10721800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Archaeosomes: New Generation of Liposomes Based on Archaeal Lipids for Drug Delivery and Biomedical Applications.
    Santhosh PB; Genova J
    ACS Omega; 2023 Jan; 8(1):1-9. PubMed ID: 36643444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential of archaeosomes as carriers of pDNA into mammalian cells.
    Attar A; Ogan A; Yucel S; Turan K
    Artif Cells Nanomed Biotechnol; 2016; 44(2):710-6. PubMed ID: 25650647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery systems for natural antioxidant compounds: Archaeosomes and archaeosomal hydrogels characterization and release study.
    González-Paredes A; Clarés-Naveros B; Ruiz-Martínez MA; Durbán-Fornieles JJ; Ramos-Cormenzana A; Monteoliva-Sánchez M
    Int J Pharm; 2011 Dec; 421(2):321-31. PubMed ID: 21986112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.